» Articles » PMID: 36922774

Factors Influencing Adherence to Anti-retroviral Therapy in Amazonian Indigenous People Living with HIV/AIDS

Overview
Publisher Biomed Central
Specialty Public Health
Date 2023 Mar 16
PMID 36922774
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Indigenous communities in Peru has been historically affected by high mortality rates attributable to HIV-AIDS infection, associated with a low access to health services, and socio-cultural barriers. In this context, the study aimed to describe factors associated with antiretroviral treatment adherence in people from Awajun and Wampis indigenous communities, living with HIV-AIDS in a Peruvian Amazonian region.

Methods: A cross-sectional study was completed with a consecutive sample of people from indigenous communities (Awajun or Wampis) living with HIV, who were receiving antiretroviral treatment for at least the last three months. Participants were recruited between October 1 and December 30, 2021, from four districts of Bagua and Condorcanqui provinces in the Amazonian region. An ad-hoc questionnaire was used to collect information about demographic, economic, and socio-cultural factors and access to health services. The Simplified Medication Adherence Questionnaire (SMAQ) was used to evaluate adherence to antiretroviral therapy. Multivariate logistic regression analysis with backward stepwise was performed to explore factors that might influence adherence.

Results: Of the 208 participants, 28.8% reported complete adherence to antiretroviral treatment. The multivariate logistic regression showed that occupation (aPR: 1.86; 95%CI 1.15-3.02), economic income (aPR: 0.64; 95%CI 0.41-0.99), and adverse reactions to antiretroviral therapy (aPR: 0.36; 95%CI 0.18-0.70) were related to complete adherence to medication.

Conclusion: Only a third of participants reported complete adherence to antiretroviral therapy. Factors associated with adherence to antiretroviral medication were related to socioeconomic conditions and adverse reactions to the therapeutic scheme. Interventions to improve adherence in indigenous people living with HIV should consider these factors in order to develop effective implementation strategies.

References
1.
Graeff S, Picolli R, Arantes R, de Oliveira Landgraf de Castro V, da Cunha R . Epidemiological aspects of HIV infection and AIDS among indigenous populations. Rev Saude Publica. 2019; 53:71. PMC: 6758848. DOI: 10.11606/S1518-8787.2019053000362. View

2.
Bhatti A, Usman M, Kandi V . Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy. Cureus. 2016; 8(3):e515. PMC: 4818110. DOI: 10.7759/cureus.515. View

3.
Negin J, Aspin C, Gadsden T, Reading C . HIV Among Indigenous peoples: A Review of the Literature on HIV-Related Behaviour Since the Beginning of the Epidemic. AIDS Behav. 2015; 19(9):1720-34. PMC: 4551545. DOI: 10.1007/s10461-015-1023-0. View

4.
Sianturi E, Perwitasari D, Islam M, Taxis K . The association between ethnicity, stigma, beliefs about medicines and adherence in people living with HIV in a rural area in Indonesia. BMC Public Health. 2019; 19(1):55. PMC: 6330480. DOI: 10.1186/s12889-019-6392-2. View

5.
Zafra-Tanaka J, Ticona-Chavez E . [Stigma related to HIV/AIDS associated with adherence to antiretroviral therapy in patients of a public hospital in Lima, Peru 2014]. Rev Peru Med Exp Salud Publica. 2017; 33(4):625-632. DOI: 10.17843/rpmesp.2016.334.2544. View